Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Non-Current Assets: 2020-2023

Historic Non-Current Assets for Cullinan Therapeutics (CGEM) over the last 3 years, with Sep 2023 value amounting to $18.0 million.

  • Cullinan Therapeutics' Non-Current Assets fell 48.82% to $18.0 million in Q3 2023 from the same period last year, while for Sep 2023 it was $18.0 million, marking a year-over-year decrease of 48.82%. This contributed to the annual value of $86.6 million for FY2022, which is 38.38% down from last year.
  • As of Q3 2023, Cullinan Therapeutics' Non-Current Assets stood at $18.0 million, which was down 24.23% from $23.7 million recorded in Q2 2023.
  • Over the past 5 years, Cullinan Therapeutics' Non-Current Assets peaked at $140.6 million during Q4 2021, and registered a low of $2.4 million during Q4 2020.
  • Moreover, its 3-year median value for Non-Current Assets was $86.6 million (2022), whereas its average is $77.9 million.
  • Its Non-Current Assets has fluctuated over the past 5 years, first skyrocketed by 5,686.87% in 2021, then slumped by 71.77% in 2022.
  • Over the past 4 years, Cullinan Therapeutics' Non-Current Assets (Quarterly) stood at $2.4 million in 2020, then skyrocketed by 5,686.87% to $140.6 million in 2021, then crashed by 38.38% to $86.6 million in 2022, then plummeted by 48.82% to $18.0 million in 2023.
  • Its Non-Current Assets was $18.0 million in Q3 2023, compared to $23.7 million in Q2 2023 and $116.0 million in Q1 2023.